According to Google DeepMind, their C2S-Scale 27B artificial intelligence model, developed on the open-source Gemma family, has identified a new potential pathway for cancer therapy by detecting cancer cells that evade the immune system (source: @GoogleDeepMind). This discovery, validated in collaboration with Yale University scientists, demonstrates how advanced AI can accelerate breakthrough drug discovery and oncology research. The practical application of C2S-Scale 27B highlights the growing role of open AI models in uncovering non-obvious therapeutic targets, offering pharmaceutical companies and biotech startups new business opportunities in precision medicine and immunotherapy.